All articles by Anthony King
-
ResearchMapping metabolite disturbances by drugs
High-throughput metabolomic profiling gives insight into unpredictable drug effects
-
ResearchLife’s ingredients discovered in samples Nasa probe returned from an asteroid
Asteroid Bennu found to contain nucleobases, amino acids and ammonia
-
FeatureLow concentration chemicals spur toxicological debate
Improved analytical techniques mean tiny amounts of endocrine disrupting compounds or PFAS can be found in many places. But is it a problem? Anthony King talks to the scientists on both sides of the fence
-
BusinessJ&J’s Intra-Cellular deal could signal more mega-mergers for 2025
£15 billion deal for neuroscience biotech aims to replace revenues from patent expiries
-
ResearchMutant moulds threaten newest antifungal drugs putting immunocompromised patients at risk
Agrichemical antifungal use is leading to fungi that can evolve resistance to novel drugs faster – even those not even on the market yet
-
ResearchmRNA therapy might one day treat deadly pre-eclampsia in pregnant women
Therapy helped pregnant mice to regrow placental blood vessels
-
BusinessOpposition to lithium mines hampers green technology supply chain
Europe and US seek to escape Chinese dominance in critical minerals
-
BusinessNorthvolt bankruptcy dents European battery industry ambitions
Swedish startup aimed to challenge Asian producers, but stumbled in scaling production
-
BusinessEurope reconsiders Alzheimer’s antibody approval
Leqembi recommended for approval with restrictions to reduce side effect risk
-
ResearchThe race to commercialise nuclear-powered batteries
‘Radiovoltaic’ devices can deliver long-lasting power to pacemakers, planetary rovers and more
-
ResearchMeteorite 200 times larger than one that killed dinosaurs reset early life
Counterintuitively, impact brought benefits too by providing microorganisms with iron and phosphorus
-
BusinessAdnoc to buy Covestro, continuing expansion into polymers
€15 billion deal sees Gulf oil producer looking to future growth beyond fuels
-
BusinessDrug companies reluctantly accept state price negotiations
As legal challenges fall flat, will industry’s claims of stifled innovation be borne out?
-
BusinessUS approves schizophrenia drug with new mode of action
Cobenfy promises to better address negative symptoms than existing antipsychotics
-
BusinessUK’s Grangemouth refinery will close in 2025
Petroineos will convert site into a fuel import terminal with loss of 400 jobs
-
ResearchTherapeutic proteins can hitch a ride on parasite to bypass blood-brain barrier
Toxoplasma could be delivery agent for protein drugs – provided parasite can be made safe
-
BusinessWeight-loss drugmakers bet billions on boosting supplies
Eli Lilly and Novo Nordisk invest to expand in-house manufacturing of GLP-1 drugs
-
NewsMetallic nodules sought by deep sea miners could be making oxygen in the depths
Water-splitting at the bottom of the Pacific holds intriguing implications for the origin of life on Earth – and further afield
-
ResearchNew gene-editing tool found in bacterium could carry out extensive genome remodelling
Highly selective mechanism can insert, remove and flip large portions of DNA
-
